Company / Net Debt per Share
MARAVAI LIFESCIENCES HOLDINGS, INC. Net Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.57
FY2025
5-year range
-$3.62 / $2.09
FY2021-FY2025
Trend
+647.6%
vs FY2024
Sector context
#38 of 82
Health Care
What the data says
Net Debt per Share changed +648% YoY in FY2025, a notable deviation from the 5-year average annual change of +86%.
Based on SEC 10-K filings.
0.57 in FY2025 with a 5-year CAGR of -47.2%.
Increased from $-0.20 to $0.57 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -47.2%
- 10-Year CAGR
- -
Sector benchmark
#45 of 82 in Health CareTop 54% of 82This company $0.57 Sector average $13.70
▼
-95.9% below sector average
Key checks
Key Insights
- MARAVAI LIFESCIENCES HOLDINGS, INC.'s net debt per share has grown for 3 consecutive years.
- In FY2025, net debt per share increased 647.6% year-over-year.
- Ranks #38 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.57 | +647.6% |
| FY2024 | -$0.10 | +47.4% |
| FY2023 | -$0.20 | +94.6% |
| FY2022 | -$3.62 | -273.3% |
| FY2021 | $2.09 | -84.9% |
| FY2020 | $13.84 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026